Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Radiation × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 6 Oropharyngeal Neoplasms 5 Glioblastoma 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Glioma 3 Carcinoma 3 Astrocytoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Hypopharyngeal Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Ependymoma 2 Burkitt Lymphoma 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Sinonasal undifferentiated carcinoma 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡